Using ketamine to help people with methamphetamine addiction
Official title: KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).
Funded at The Emmes Company, LLC · NIH-10720987 · Data updated 2026-11-12
This study is looking at whether ketamine can help people who are trying to overcome methamphetamine addiction by reducing cravings and improving their mental health, and it’s designed for those who are struggling with this issue.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project start | September 28, 2022 |
| Project end | August 21, 2025 |
| Funding year | 2022 |
| Award (this year) | $1,399,972 |
| NIH project number | 75N95022D00017-0-759502200004-1 |
| Project ID | NIH-10720987 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults diagnosed with methamphetamine use disorder who are seeking treatment.
✕Less likely to help
Patients who are not struggling with methamphetamine use disorder or those with contraindications to ketamine may not benefit from this research.
What this research studies
This research investigates the potential of ketamine as a treatment for individuals struggling with methamphetamine use disorder. Participants will receive ketamine infusions in a controlled setting, with the aim of reducing cravings and improving overall mental health. The study will monitor participants' progress over time to assess the effectiveness of this treatment approach. By focusing on substance misuse, the research seeks to provide new therapeutic options for those affected by addiction.
Why it matters
Potential benefit: If successful, this research could offer a novel treatment option for individuals with methamphetamine use disorder, potentially leading to improved recovery outcomes.
How similar studies have gone: Previous research has shown promising results for ketamine in treating other substance use disorders, suggesting potential for success in this area as well.
Where this research is happening
-
The Emmes Company, LLC
Rockville, United States Active
Researchers
- Principal investigator: Mccormack, Jennifer — The Emmes Company, LLC
- Study coordinator: Mccormack, Jennifer
Related research
Other NIH-funded projects on the same topics.
-
Ketamine to boost fear extinction and memory on PTSD patients
A study testing whether ketamine can help people with PTSD better relearn and forget fear when given in a guided treatment plan.
-
Automated self-acceptance training plus ketamine to extend antidepressant benefits
A study tests whether adding a quick computerized self-positivity training after ketamine can prolong relief from depression for people seeking ketamine treatment.
-
Ultrasound-triggered ketamine delivery to a brain region to treat chronic pain
A Stanford team is testing a new way to give ketamine exactly where it’s needed in the brain to relieve chronic pain without opioids.
-
Ketamine-assisted care plan to help Veterans with chronic back pain and depression
A program for Veterans with chronic low back pain and depression that uses ketamine infusions followed by a brief narrative therapy to sustain relief from pain and mood improvement.
-
Ketamine to reduce postpartum depression and pain after cesarean delivery
This grant explores a ketamine approach to help new mothers after cesarean delivery feel better sooner and with less pain.
-
Calming cue-triggered cravings in methamphetamine use
Seeing if teaching people with methamphetamine use disorder a thinking-based skill (cognitive reappraisal) can reduce brain and craving reactions to drug cues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.